Form 13-F position report

ABVC BIOPHARMA INC

Reported by Avantax Planning Partners Inc

ABVC CUSIP 00091F304 Manager CIK 0001005441

Reported 143,968 shares, up 104,968 (269.1%) from the prior quarter.

Reported value 218.7%; share count 269.1% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q4 2024
Shares 143,968 Quarter-end amount reported
Reported value $84,941 Fair value at quarter end
Consecutive quarters held 3 Through Q4 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2024-06-30 30186
2024-09-30 26653
2024-12-31 84941
2025-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

4 quarters
Quarterly reported position history for ABVC BIOPHARMA INC held by Avantax Planning Partners Inc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2025 Reduced 0 -143,968 (-100.0%) 0 $0 2025-04-29
Q4 2024 Added 143,968 +104,968 (269.1%) < 0.01% $84,941 2025-02-07
Q3 2024 Unchanged 39,000 0 (0.0%) < 0.01% $26,653 2024-11-14
Q2 2024 New 39,000 +39,000 (0.0%) < 0.01% $30,186 2024-08-09

Who else reported the position

14 managers reported ABVC BIOPHARMA INC for Q4 2024.

Managers reporting ABVC BIOPHARMA INC in Q4 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Avantax Planning Partners Inc This report Added 143,968 +104,968 < 0.01% $84,941 3 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 79,285 +7,678 < 0.01% $46,777 6 qtrs
VANGUARD GROUP INC Unchanged 46,947 0 < 0.01% $27,699 6 qtrs
CITADEL ADVISORS LLC New 40,743 +40,743 < 0.01% $24,038 6 qtrs
XTX Topco Ltd Added 34,405 +11,000 < 0.01% $20,299 3 qtrs
NORTHERN TRUST CORPORATION Unchanged 19,135 0 < 0.01% $11,290 3 qtrs
Virtu Financial LLC New 15,935 +15,935 < 0.01% $9,000 1 qtr
STATE STREET CORPORATION Unchanged 12,900 0 < 0.01% $7,611 3 qtrs
TWO SIGMA SECURITIES LLC Added 12,593 +196 < 0.01% $7,430 2 qtrs
Tower Research Capital LLC TRC Reduced 2,563 -60 < 0.01% $1,512 6 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2024
Filed
February 07, 2025
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
0
Shared
0
None
143,968

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.